ロード中...
(131)I-Tositumomab Myeloablative Radioimmunotherapy for Non-Hodgkin Lymphoma: Radiation Dose to Testes
PURPOSE: To investigate radiation dose to testes delivered by radiolabeled anti-CD20 antibody and its effects on male sex hormone levels. METHODS: Testicular uptake and retention of (131)I tositumomab were measured and testicular absorbed doses were calculated for 67 male patients (54 ± 11 years old...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3703155/ https://ncbi.nlm.nih.gov/pubmed/22955187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNM.0b013e328358d34b |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|